Perioperative risk assessment and management of oral implant restoration in ASA Ⅲ cardiovascular disease patients

doi:10.12337/zgkqzzxzz.2024.08.006

Abstract

Abstract: With the widespread adoption of implant technology, ensuring the safe implementation of implant surgery for patients with complex systemic diseases has become a challenge that implant dentists must confront. Based on the patient's physical condition, the American Society of Anesthesiologists (ASA) classifies the perioperative risk. Patients at ASA Ⅰ~Ⅱ have an extremely low risk of surgery, while those at ASA Ⅳ and above have a very high risk and are not suitable for surgery. How to assess perioperative risks, perform implant surgery, and reduce serious perioperative complications for ASAⅢ patients is a question that more and more implant doctors are focusing on. This article aims to start with the most common clinical patients with cardiovascular diseases at ASAⅢ, exploring the risk assessment, prevention, complication management of oral implant surgery for such patients, providing a reference for the safe implant restoration for this category of patients.

Key words: Dental implantation, Perioperative period, Cardiovascular diseases, American Society of Anesthesiologists class Ⅲ

Zhang Yanting, Wang Wei, Chen Li, Zhao Wen, Zhou Wei. Perioperative risk assessment and management of oral implant restoration in ASA Ⅲ cardiovascular disease patients[J]. Chinese Journal of Oral Implantology, 2024, 29(4): 328-335.

References

[1] Masri D, Masri-Iraqi H, Naishlos S, et al.Implant-supported prosthesis is a viable treatment alternative for american society of anesthesiology physical status 3 individuals a retrospective cohort study[J]. J Clin Med, 2022, 11(7):2002. DOI: 10.3390/jcm11072002.
[2] Horvath B, Kloesel B, Todd MM, et al.The evolution, current value, and future of the american society of anesthesiologists physical status classification system[J]. Anesthesiology, 2021, 135(5):904-919. DOI: 10.1097/ALN.0000000000003947.
[3] Miller RD, Eriksson LI, Fleisher LA, et al.Miller's anesthesia[M]. 7th ed. Philadelphia: Churchill Livingstone/Elsevier, 2010.
[4] Irlbeck T, Zwißler B, Bauer A.ASA classification: transition in the course of time and depiction in the literature[J]. Anaesthesist, 2017, 66(1):5-10. DOI: 10.1007/s00101-016-0246-4.
[5] Kearney PM, Whelton M, Reynolds K, et al.Global burden of hypertension: analysis of worldwide data[J]. Lancet, 2005, 365(9455):217-223. DOI: 10.1016/S0140-6736(05)17741-1.
[6] Lu J, Lu Y, Wang X, et al.Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390(10112):2549-2558. DOI: 10.1016/S0140-6736(17)32478-9.
[7] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6):521-545. DOI: 10.3969/j.issn.1000-3614.2021.06.001.
[8] Kristensen SD, Knuuti J, Saraste A, et al.2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J]. Eur Heart J. 2014,35(35):2383-2431. DOI: 10.1093/eurheartj/ehu282.
[9] Wijeysundera DN, Pearse RM, Shulman MA, et al.Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study[J]. Lancet, 2018, 391(10140):2631-2640. DOI: 10.1016/S0140-6736(18)31131-0.
[10] Hartle A, McCormack T, Carlisle J, et al. The measurement of adult blood pressure and management of hypertension before elective surgery: joint guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society[J]. Anaesthesia, 2016, 71(3):326-337. DOI: 10.1111/anae.13348.
[11] Anisimova EN, Orekhova IV, Sokhov ST, et al.The choice of local anesthesia for patients with hypertension in dental practice[J]. Stomatologiia (Mosk), 2016, 95(1):31-34. DOI: 10.17116/stomat201695131-34.
[12] Chen YJ, Wang YJ.Influence of systemic diseases on the diagnosis and treatment of dental diseases and prevention of related risks[J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2022, 57(5):474-480. DOI: 10.3760/cma.j.cn112144-20220305-00094.
[13] 丁芳, 杨红霞, 孟焕新. 伴心脑血管疾病患者牙周治疗的风险及防范对策[J]. 中华口腔医学杂志, 2022, 57(6):563-568. DOI: 10.3760/cma.j.cn112144-20220428-00222.
[14] Hawn MT, Graham LA, Richman JS, et al.Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents[J]. JAMA, 2013, 310(14):1462-1472. DOI: 10.1001/jama.2013.278787.
[15] Herman WW, Ferguson HW.Dental care for patients with heart failure: an update[J]. J Am Dent Assoc, 2010, 141(7):845-853. DOI: 10.14219/jada.archive.2010.0282.
[16] Lyons WL.Approach to evaluating the multimorbid patient with cardiovascular disease undergoing noncardiac surgery[J]. Clin Geriatr Med, 2016, 32(2):347-358. DOI: 10.1016/j.cger.2016.01.007.
[17] 中华口腔医学会镇静镇痛专业委员会.非麻醉医师实施口腔诊疗适度镇静/镇痛专家共识: T/CHSA 003-2023[S].北京:中华口腔医学会,2023.
[18] 黄志权,张大明.微创外科技术在口腔颌面外科中的应用[J].口腔疾病防治,2018,26(2):75-82. DOI: 10.12016/j.issn.2096-1456.2018.02.002.
[19] Chatterjee A, Hage FG.Guidelines in review: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J]. J Nucl Cardiol, 2015, 22(1):158-161. DOI: 10.1007/s12350-014-9992-3.
[20] Serrera Figallo MA, Velázquez Cayón RT, Torres Lagares D, et al.Use of anesthetics associated to vasoconstrictors for dentistry in patients with cardiopathies. Review of the literature published in the last decade[J]. J Clin Exp Dent, 2012, 4(2):e107-e111. DOI: 10.4317/jced.50590.
[21] 中华医学会麻醉学分会, 麻醉后监测治疗专家共识[J]. 临床麻醉学杂志, 2021, 37(1):89-94. DOI:10.12089/jca.2021.01.020
[22] Han Chong,He Dongning,Yu Feiyan,et al.Research progress on the mechanism and treatment of pain after oral implants[J]. Int J Stomatol, 2024, 51(1): 99-106. DOI:10.7518/gjkq. 2024002.
[23] 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 冠心病双联抗血小板治疗中国专家共识[J]. 中华心血管病杂志, 2021, 49(5):432-454. DOI: 10.3760/cma.j.cn112148-20210125-00088.
[24] Valgimigli M, Bueno H, Byrne RA, et al.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2018, 39(3):213-260. DOI: 10.1093/eurheartj/ehx419.
[25] Chaushu L, Perez N, Botticelli D, et al.The effect of anticoagulants on early implant failure: a retrospective cohort study[J]. J Funct Biomater, 2023, 14(4):186. DOI: 10.3390/jfb14040186.
[26] Conrad HJ, Jung J, Barczak M, et al.Retrospective cohort study of the predictors of implant failure in the posterior maxilla[J]. Int J Oral Maxillofac Implants, 2011, 26(1):154-162.
[27] Zinser MJ, Randelzhofer P, Kuiper L, et al.The predictors of implant failure after maxillary sinus floor augmentation and reconstruction: a retrospective study of 1045 consecutive implants[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 115(5):571-582. DOI: 10.1016/j.oooo.2012.06.015.
[28] D'Ambrosio F, Amato A, Chiacchio A, et al. Do systemic diseases and medications influence dental implant osseointegration and dental implant health? An umbrella review[J]. Dent J (Basel), 2023, 11(6):146. DOI: 10.3390/dj11060146.
[29] Schimmel M, Srinivasan M, McKenna G, et al. Effect of advanced age and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis[J]. Clin Oral Implants Res, 2018, 29(Suppl 16):311-330. DOI: 10.1111/clr.13288.